as a deeper depletion of autoreactive MBCs could be established by adding B-cell-depleting therapy after the initiation of BLM. References: [1]Arends EJ et al. Long-term effects of combined B cell ...

An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according ...

Boehringer Ingelheim has joined the surge of companies entering the B-cell depletion space. But while its peers have largely focused on CAR-Ts and bispecifics, the German drugmaker has paid Cue ...

Upon comparing the composition of responders and non-responders, the researchers found responder tumors enriched for B cells, immune cells involved in humoral immunity. In addition, compared to ...

The results indicate a prolonged duration of response, significant B-cell depletion, and a well-tolerated safety profile when AlloNK is combined with rituximab. Additionally, the company will ...

Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of 113 health care workers in Catalonia who were followed for three years.

Not only that, but it also allows sustained B-cell depletion when a patient is treated in a chronic fashion with obexelimab. The competitive advantage of this could end up being the ability for ...

Monoclonal B-cell lymphocytosis is when your body produces an elevated number of identical B cells. In some cases, it can develop into chronic lymphocytic leukemia. Monoclonal B-cell lymphocytosis ...